Precision Optics Corporation, Inc.
NASDAQ:POCIMedical - Instruments & Supplies
+$0.14 today
- Market cap
- $53.44M
- Beta
- 0.32
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.63
Volume 0.03M
Average 0.05M
POCI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Precision Optics Corporation, Inc.NASDAQ: POCI
Research & Development · Q3 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q3 FY2026 research & development of $267.32K rose 26.5% year over year, ahead of the -17.7% change in trailing-twelve-month research & development. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at +20.2% a year.
Context
- Research & development amounted to 6.1% of revenue in FY2025, up 0.9 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +26.5% holds above the trailing-twelve-month pace of -17.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 1.16M USD
- Year-over-year change
- +17.9%
- 4-year CAGR
- +16.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 1.16M | +17.9% |
| FY2024 | 2024-06-30 | 981.78K | -1.1% |
| FY2023 | 2023-06-30 | 992.38K | +48.9% |
| FY2022 | 2022-06-30 | 666.48K | +6.8% |
| FY2021 | 2021-06-30 | 624.25K | — |
Research & Development vs competitors
How POCI compares with its peers on the latest reported figures
- POCI's LTM Mar 2026 research & development of $1.06M is the lowest of the 3 companies compared; the peer median is $4.12M.
- Its year-over-year change of -17.7% is the 2nd highest of 3, against a peer median of -13.8%.
- Research & development amounts to 3.7% of revenue for POCI, versus a peer median of 48.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.78M | +20.9% | +40.9% | 16.4% | |
| LTM Apr 2026 | $1.45M | -48.6% | +24.4% | 80.7% | |
| LTM Mar 2026 | $1.06M | -17.7% | +20.2% | 3.7% | |
| Peer median (excluding POCI) | $4.12M | -13.8% | +32.7% | 48.6% | |
Competitors are the stored peer set for POCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 10.67M | 15.68M | 21.04M | 19.1M | 19.09M |
| Cost of Revenue | 7.24M | 10.75M | 13.31M | 13.31M | 15.69M |
| Gross Profit | 3.43M | 4.93M | 7.73M | 5.8M | 3.4M |
| Gross Margin | 32.2% | 31.4% | 36.8% | 30.3% | 17.8% |
| Research & Development | 624.25K | 666.48K | 992.38K | 981.78K | 1.16M |
| Selling, General & Admin | 3.71M | 5.61M | 7.38M | 7.54M | 7.8M |
| Operating Expenses | 4.34M | 6.28M | 8.37M | 8.52M | 8.96M |
| Depreciation & Amortization | 146.8K | 245.24K | 210.74K | 212.38K | 212.44K |
| EBITDA | 50.18K | (526.57K) | 286.99K | (2.51M) | (5.34M) |
| EBITDA Margin | 0.5% | -3.4% | 1.4% | -13.1% | -28.0% |
| Operating Income | (905.58K) | (1.35M) | (638.55K) | (2.72M) | (5.55M) |
| Operating Margin | -8.5% | -8.6% | -3.0% | -14.3% | -29.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.3K | 155.66K | 218.93K | 225.11K | 227.02K |
| Other Income / Expenses | 803.66K | 586.43K | 495.87K | (225.11K) | (227.02K) |
| Income Before Tax | (101.92K) | (927.46K) | (142.68K) | (2.95M) | (5.78M) |
| Pre-Tax Margin | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
| Income Tax Expense | 912 | 952 | 1.94K | 1.94K | 1.94K |
| Net Income | (102.84K) | (928.42K) | (144.61K) | (2.95M) | (5.78M) |
| Net Margin | -1.0% | -5.9% | -0.7% | -15.4% | -30.3% |
| EPS (Basic) | (0.02) | (0.18) | (0.03) | (0.49) | (0.85) |
| EPS (Diluted) | (0.02) | (0.18) | (0.03) | (0.49) | (0.85) |
| Weighted Avg Shares | 4.43M | 5.3M | 5.67M | 6.07M | 6.79M |
| Weighted Avg Shares (Diluted) | 4.43M | 5.3M | 5.67M | 6.07M | 6.79M |
Precision Optics Corporation, Inc.
NASDAQ:POCI
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.